Abbott Laboratories (ABT) Tops Q2 EPS by 1c; Raises FY11 Outlook
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $111.25 -0.02%
Financial Fact:
Basic Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Basic Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q2 EPS of $1.12, $0.01 better than the analyst estimate of $1.11. Revenue for the quarter came in at $9.62 billion versus the consensus estimate of $9.56 billion.
Sees FY2011 EPS of $4.58-$4.68, versus prior guidance of $4.54-$4.64 and the consensus of $4.60.
Sees FY2011 EPS of $4.58-$4.68, versus prior guidance of $4.54-$4.64 and the consensus of $4.60.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
